WuXi Provides Enhanced Genomics Services for Chinese Researchers

We are pleased to announce that our genome center will provide Chinese researchers who use our gene sequencing services with access to the integrated sequence analysis capabilities of NextCODE Health, a bioinformatics company based...

WuXi’s BIO 2015 Recap

The 2015 International BIO Convention in Philadelphia brought together over 15,000 industry leaders from around the world interested in innovation, partnership, and progress in the biotechnology and healthcare industries.  At the...

WuXi Congratulates MSD on Receiving FDA Approval of ZEPATIER™

Congratulations to MSD, known as Merck & Co., Inc. in the U.S. and Canada, for receiving approval from the FDA for ZEPATIER™ (elbasvir / grazoprevir) for the treatment of adult patients...

WuXi Webinar “Demystifying Product Development in China” Attracts Big Audience

We held the complimentary webinar to offer insights into working in China, an operating environment that has remained a mystery to many despite its status as one of the industry’s most...
video

WuXi Global 2017 Forum Recap

More than 1,500 industry leaders gathered at the WuXi Global Forum 2017. The annual event, held in San Francisco during the J.P. Morgan Healthcare Conference on Jan. 10, promotes new thinking...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS